How Soon Will Novavax File for Emergency Use Authorization for Its COVID Vaccine?

Novavax (NASDAQ: NVAX) wowed investors with its announcement in March of high efficacy for its COVID-19 vaccine candidate NVX-CoV2373. The next big step for the biotech is to file for Emergency Use Authorizations (EUAs) with regulatory agencies. In this Motley Fool Live video recorded on April 7, Motley Fool contributors Keith Speights and Brian Orelli discuss what the timeline might be for Novavax filing for EUAs for NVX-CoV2373.

Continue reading

Source Fool.com